Format

Send to

Choose Destination
J Infect Dis. 2003 Dec 15;188(12):1885-91. Epub 2003 Dec 8.

P fimbria-specific B cell responses in patients with urinary tract infection.

Author information

1
Division of Infectious Diseases, Department of Medicine, Helsinki University Central Hospital, Helsinki, Finland. anu.kantele@hus.fi

Abstract

Local immune response may be important in defense against urinary tract infection (UTI). P fimbria, an important virulence factor of Escherichia coli, is a noteworthy candidate for use in a vaccine against pyelonephritis (PN). Eleven patients with PN and 14 patients with lower urinary tract infection (LUTI) caused by E. coli were studied for mucosa-derived antibody-secreting cells (ASCs) and for urinary antibodies. In the 10 patients with P-fimbriated (P+) E. coli, an ASC response to P fimbria was found in 5 of 5 patients who had PN and 1 of 5 patients who had LUTI. The response to P fimbria was stronger among patients with P+ PN than among patients with PN caused by non-P-fimbriated E. coli (P-) (P<.001) or patients with P+ LUTI (P<.001). The response to P fimbria was also stronger than the response to outer-membrane protein A among all patients with PN. P fimbria-specific urinary immunoglobulin A antibody levels were higher among patients with P+ PN than those with P- PN. The results show a P fimbria-specific local immune response, which further encourages the use of P fimbria in locally administrable UTI vaccines.

PMID:
14673769
DOI:
10.1086/380097
[Indexed for MEDLINE]

Supplemental Content

Full text links

Icon for Silverchair Information Systems
Loading ...
Support Center